The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real world evidence on long-term survival of patients with endometrial cancer in Germany: Analysis of population-based cancer registry data on 49808 women.
 
Lukas Chinczewski
No Relationships to Disclose
 
Dario Zocholl
No Relationships to Disclose
 
Alexandra Wagner
No Relationships to Disclose
 
Radoslav Chekerov
No Relationships to Disclose
 
Elena Ioana Braicu
Honoraria - AstraZeneca; GlaxoSmithKline; Merck
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline
Research Funding - AstraZeneca (Inst); Bayer (Inst); Clovis Oncology (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Merck (Inst); Resolve Digital (Inst)
Travel, Accommodations, Expenses - AstraZeneca
Other Relationship - North-East German Society for Gynecological Oncology (NOGGO)
 
Jalid Sehouli
Honoraria - AstraZeneca; Bayer; Clovis Oncology; Eisai; GlaxoSmithKline; Johnson & Johnson; MSD Oncology; Olympus Medical Systems; Pfizer; PharmaMar; Tesaro; Teva
Consulting or Advisory Role - Alkermes; AstraZeneca; Clovis Oncology; GlaxoSmithKline; Ingress Health; Johnson & Johnson; Lilly; Merck; MSD Oncology; Novartis; Novocure; Pfizer; PharmaMar; Riemser; Roche; Sobi; Tesaro
Research Funding - AstraZeneca (Inst); Bayer (Inst); Clovis Oncology (Inst); Merck (Inst); MSD Oncology (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; MSD Oncology; Olympus; PharmaMar; Roche Pharma AG; Tesaro; Tesaro